Verastem Inc (NASDAQ:VSTM)
| 11.94 Delayed Data As of Jun 02 |  -0.12 / -1.00%Today’s Change | 3.47 Today|||52-Week Range 17.64 | +147.20% Year-to-Date |
Latest VSTM News | Press Releases
No recent news for Verastem Inc.
Today’s Trading
| Previous close | 12.06 |
| Today’s open | 11.68 |
| Day’s range | 11.45 - 12.01 |
| Volume | 13,623 |
| Average volume (3 months) | 167,095 |
| Market cap | $200.2M |
Data as of 3:59pm ET, 06/02/2023
Growth & Valuation
| Earnings growth (last year) | +6.64% |
| Earnings growth (this year) | +15.71% |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 4.22 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SGMOSangamo Therapeutics... | +0.05 | +4.50% |
| SELBSelecta Biosciences ... | +0.03 | +2.40% |
| XOMAXOMA Corp | +0.93 | +5.47% |
| KZRKezar Life Sciences ... | +0.10 | +3.42% |
Data as of 4:00pm ET, 06/02/2023
Financials
| Next reporting date | August 8, 2023 |
| EPS forecast (this quarter) | -$1.19 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$73.8M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Needham, Massachusetts |
Forecasts
